Publication | Closed Access
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
86
Citations
26
References
2014
Year
Gastrointestinal OncologyMedicineNeoadjuvant CapecitabinePathologyCancer TreatmentOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1